Susquehanna International Group
STAB

Susquehanna International Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Susquehanna International Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,500
Closed -$40K – 14269
2021
Q3 		$40K Buy
+17,500
New +$66.3K ﹤0.01% 12422
2014
Q1 		– Sell
-1,615
Closed -$38K – 9577
2013
Q4 		$38K Sell
1,615
-4,545
-74% -$124K ﹤0.01% 8839
2013
Q3 		$193K Buy
6,160
+865
+16% +$28.6K ﹤0.01% 7797
2013
Q2 		$167K Buy
+5,295
New +$182K ﹤0.01% 7561

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's STAB Position: Q4 2022 in Review

Susquehanna International Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2022, closing a stake of 16,228 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in STAB in Q2 2013 and held it in 13 quarters. The position peaked at $131K in Q2 2021. 29 funds tracked by Wall St. Rank hold STAB as of Q4 2022.

  • Susquehanna International Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 16,228 Statera Biopharma, Inc. Common Stock shares in Q4 2022, an estimated $2K.
  • Susquehanna International Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • Susquehanna International Group's Statera Biopharma, Inc. Common Stock position peaked at $131K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.